Allogeneic hematopoietic stem cell transplantation for primary myelodysplastic syndrome Transplante alogênico de células progenitoras hematopoiéticas para síndrome mielodisplásica primária

Characteristics and outcomes of 52 patients with myelodysplastic syndrome (MDS) who underwent allogeneic hematopoietic stem cell transplantation (allo-HSCT) were analyzed. Median age was 30 years (range 2-61 years) and median time from diagnosis to allo-HSCT was 10 months (range 1-161 months). Thirt...

Descripció completa

Dades bibliogràfiques

Autors principals:	Carlos R. Medeiros, Nilo E. Gardin, Ricardo Pasquini
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2004-01-01
Col·lecció:	Revista Brasileira de Hematologia e Hemoterapia
Matèries:	Síndrome mielodisplásica transplante alogênico de células progenitoras hematopoiéticas leucemia mielóide aguda Myelodysplastic syndrome allogeneic hematopoietic stem cell transplantation acute myeloid leukemia
Accés en línia:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842004000200002
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!